Podofilox (Actavis Pharma, Inc.)


Welcome to the PulseAid listing for the Podofilox drug offered from Actavis Pharma, Inc.. This Decreased Mitosis [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Actavis Pharma, Inc.
NON-PROPRIETARY NAME: Podofilox
SUBSTANCE NAME: PODOFILOX
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Mitosis [PE]
ROUTE: TOPICAL
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 1990-12-13
END MARKETING DATE: 0000-00-00


Podofilox HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPodofilox from Actavis Pharma, Inc.
LABELER NAME: Actavis Pharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/mL)
START MARKETING DATE: 1990-12-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0591-3204_ac1ad39a-ecdf-419e-830b-c1727a7514a9
PRODUCT NDC: 0591-3204
APPLICATION NUMBER: NDA019795

Other PODOFILOX Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Condylox
Paddock Laboratories, LLCPODOFILOX
Physicians Total Care, Inc.Podofilox